Engineered Recombinant Antibody Potently Neutralizes Type B Botulinum Neurotoxins.


Lou J., GEREN I. N. , Consuelo G., Forsyth C. M. , Wen W., Knopp K., ...More

The 43rd Interagency Botulism Research Coordinating Committee (IBRCC) conference in Washington, United States Of America, 01 November 2006

  • Publication Type: Conference Paper / Full Text
  • Country: United States Of America